Esmolol nonclinical toxicology: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Nonclinical Toxicology== | ==Nonclinical Toxicology== | ||
Because of its short term usage non of the followings have been studied:<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BREVIBLOC (ESMOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=595cc3d5-1306-4828-aefa-5595219ffd62 | publisher = | date = | accessdate = }}</ref> | Because of its short term usage non of the followings have been studied:<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BREVIBLOC (ESMOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=595cc3d5-1306-4828-aefa-5595219ffd62 | publisher = | date = | accessdate = }}</ref> | ||
:*'''Carcinogenicity''' | :*'''[[Carcinogenicity]]''' | ||
:*'''Mutagenicity''' | :*'''[[Mutagenicity]]''' | ||
:*'''Fertility''' | :*'''[[Fertility]]''' | ||
==References== | ==References== | ||
Revision as of 19:47, 20 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Nonclinical Toxicology
Because of its short term usage non of the followings have been studied:[1]
References
Adapted from the FDA Package Insert.